FDA Orange Book · active-ingredient family
Ipratropium bromide
Ipratropium bromide is approved as 5 brand and 28 generic applications in the FDA Orange Book, with their therapeutic-equivalence codes, listed patents, and marketing exclusivity.
Reference-listed drug:ATROVENT HFA · NDA 021527
5
Brand (NDA)
28
Generics (ANDA)
1
Listed patents
1
Exclusivity periods
Brand (NDA) products · aerosol, metered, solution, spray, metered
| Product | Applicant | Application | TE | Approved | |
|---|---|---|---|---|---|
| ATROVENT HFARLD | BOEHRINGER INGELHEIM | NDA 021527 | AB | Nov 27, 2004 | |
| ATROVENTRLD | BOEHRINGER INGELHEIM | NDA 020393 | — | Oct 20, 1995 | |
| ATROVENTRLD | BOEHRINGER INGELHEIM | NDA 020394 | — | Oct 20, 1995 | |
| ATROVENTRLD | BOEHRINGER INGELHEIM | NDA 020228 | — | Sep 29, 1993 | |
| ATROVENT | BOEHRINGER INGELHEIM | NDA 019085 | — | Dec 29, 1986 |
Generic (ANDA) products (28)
| Product | Applicant | Application | TE | Approved | |
|---|---|---|---|---|---|
| IPRATROPIUM BROMIDE | ARMSTRONG PHARMS | ANDA 217953 | AB | Feb 23, 2026 | |
| IPRATROPIUM BROMIDE | LUPIN | ANDA 217912 | AB | Feb 07, 2025 | |
| IPRATROPIUM BROMIDE | LUPIN | ANDA 217886 | AB | Jan 27, 2025 | |
| IPRATROPIUM BROMIDE | RUBICON RESEARCH | ANDA 219222 | AB | Jan 14, 2025 | |
| IPRATROPIUM BROMIDE | RUBICON RESEARCH | ANDA 219221 | AB | Nov 15, 2024 | |
| IPRATROPIUM BROMIDE | AMNEAL | ANDA 215104 | AB | Aug 16, 2022 | |
| IPRATROPIUM BROMIDE | AMNEAL | ANDA 215105 | AB | Aug 16, 2022 | |
| IPRATROPIUM BROMIDE | SUN PHARM | ANDA 207903 | — | Jan 03, 2017 | |
| IPRATROPIUM BROMIDE | LUOXIN AUROVITAS | ANDA 206543 | AN | Oct 27, 2016 | |
| IPRATROPIUM BROMIDE | LANDELA PHARM | ANDA 077072 | — | Jul 19, 2005 | |
| IPRATROPIUM BROMIDE | WATSON LABS | ANDA 076291 | — | May 09, 2005 | |
| IPRATROPIUM BROMIDE | HIKMA | ANDA 076664 | AB | Nov 05, 2003 | |
| IPRATROPIUM BROMIDE | HIKMA | ANDA 076598 | AB | Nov 05, 2003 | |
| IPRATROPIUM BROMIDE | APOTEX INC | ANDA 076156 | AB | Apr 18, 2003 | |
| IPRATROPIUM BROMIDE | APOTEX INC | ANDA 076155 | AB | Apr 18, 2003 | |
| IPRATROPIUM BROMIDE | AUROBINDO PHARMA USA | ANDA 075552 | — | Mar 31, 2003 | |
| IPRATROPIUM BROMIDE | AUROBINDO PHARMA USA | ANDA 075553 | — | Mar 31, 2003 | |
| IPRATROPIUM BROMIDE | BAUSCH | ANDA 076025 | AB | Mar 31, 2003 | |
| IPRATROPIUM BROMIDE | BAUSCH | ANDA 076103 | AB | Mar 31, 2003 | |
| IPRATROPIUM BROMIDE | ROXANE | ANDA 075867 | — | Jul 22, 2002 | |
| IPRATROPIUM BROMIDE | BAUSCH | ANDA 075835 | — | Oct 15, 2001 | |
| IPRATROPIUM BROMIDE | NEPHRON | ANDA 075562 | AN | Sep 27, 2001 | |
| IPRATROPIUM BROMIDE | APOTEX INC | ANDA 075441 | — | Mar 28, 2001 | |
| IPRATROPIUM BROMIDE | RITEDOSE CORP | ANDA 075693 | AN | Jan 26, 2001 | |
| IPRATROPIUM BROMIDE | ZENNOVA | ANDA 075507 | — | Jan 19, 2001 | |
| IPRATROPIUM BROMIDE | TEVA PHARMS USA | ANDA 075313 | — | Feb 07, 2000 | |
| IPRATROPIUM BROMIDE | ACTAVIS MID ATLANTIC | ANDA 075111 | — | Apr 22, 1999 | |
| IPRATROPIUM BROMIDE | PHARMOBEDIENT | ANDA 074755 | — | Jan 10, 1997 |
Marketing exclusivity (1)
- PCPatent-challenge (180-day generic) exclusivity
Oct 13, 2026
in 4 mo
Listed patents (1)
| Patent | Expires | In | Type |
|---|---|---|---|
| 8474447 | Jan 17, 2030 | in 3 yr 8 mo | ProductDelisted |
Ipratropium bromide — frequently asked questions
Generics, reference-listed drug, patents, and exclusivity for this active ingredient, from the FDA Orange Book.

